EP1729821
COMPOSITIONS AND METHODS FOR TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS
:
EP einkaleyfi: Þýðing ekki lögð inn:
3.3.2005:
17.7.2013:
05731866.9
:
2.3.2025
:
COMPOSITIONS AND METHODS FOR TOPICAL APPLICATION AND TRANSDERMAL DELIVERY OF BOTULINUM TOXINS
3.3.2005
17.7.2013
:
ReVance Therapeutics, Inc.:
7555 Gateway Blvd., 94560, Newark, CA, US
:
DAKE, Michael D.:
Stanford, California, US
:
WAUGH, Jacob M.:
San Francisco, California, US
:
550015 P:
3.3.2004:
US
:
WO2005084410:
3.3.2005
:
A61K 51/00, A61K 39/42, A61K 39/40, A61K 47/18, A61K 47/42